A 73-year-old man with metastatic squamous cell carcinoma of the lung is admitted with colicky abdominal pain, constipation, and mild confusion.
A 73-year-old man with metastatic squamous cell carcinoma of the lung is admitted with colicky abdominal pain, constipation, and mild confusion. He has recently commenced pembrolizumab, an immunotherapy agent. He has a history of type 2 diabetes mellitus and hypertension. His current drug history includes aspirin, ramipril, bendroflumethiazide, furosemide, gliclazide and metformin. He lives alone and is normally independent. His initial observations are: HR 100, BP 100/50 mmHg, SATS: 98% on air, RR 18, apyrexial.
After 48 hours of fluid resuscitation, repeat bloods are undertaken:
His biochemistry shows:
| Na⁺ | 138 mmol/L | (133-146 mmol/L) |
| K⁺ | 4.1 mmol/L | (3.5-5.3 mmol/L) |
| Urea | 12.2 mmol/L | (2.5-7.8 mmol/L) |
| Creatinine | 151 µmol/L | (80-115 µmol/L) |
| eGFR | 39 ml/min | (>90 ml/min) |
| Corrected Ca²⁺ | 3.58 mmol/L | (2.20-2.60 mmol/L) |
| Mg²⁺ | 0.89 mmol/L | (0.70-1.05 mmol/L) |
What is the best treatment to correct malignant hypercalcaemia in this patient?
Take your subscriptions with you
Our mobile app allows you to access your interview and exam question banks wherever you are.